News Releases Year None202420232022202120202019201820172016 Apr 11, 2024 Leap Therapeutics Announces $40 Million Private Placement Mar 18, 2024 Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results Jan 16, 2024 Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium Jan 03, 2024 Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference Jan 02, 2024 Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients